The purpose of the article is to provide an analytical overview of achievements and problems of vaccination in worldwide and in Russia. Article is showing that already, elimination of measles and rubella from the Americas providing proof in principle of the feasibility of their ultimate global eradication Authors analyzed the state of vaccination affairs in Russia. It is necessary to expand the National immunization schedule of preventive vaccinations. The main problems of vaccine prevention are outlined and suggested the ways of their solution.

I National Scientific and Educational Congress «Oncological problems from menarche to menopause» was held on 13 - 15 February 2017 in Moscow, during which there was the Panel discussion of leading experts of the Russian Federation on the need to control HPV associated diseases. The article presents the main messages from the speakers of the Panel discussion

The high prevalence of chronic bronchitis (CB) among young people, and significant pharmaco-economic costs of health care for treatment of this disease actualizes the search for new solutions for the prevention of exacerbations. The goal is to prove the clinical and economic efficacy of vaccination in a pneumococcal 13-valent conjugate vaccine for the prevention of exacerbations of chronic bronchitis in persons of young age. Materials and methods. It was compared 2 groups: vaccinated with the use of pneumococcal 13-valent conjugate vaccine (n = 57), and not vaccinated against pneumococcal infection (n = 129). Endpoints were: number of exacerbations of chronic bronchitis, including the number of outpatient and inpatient cases, the number of pneumonias per year. Statistical processing of the obtained material was carried out using PPP - Statistica 12. The results and discussion. In the group of the 129 of patients who have not received PCV13 vaccination, marked by the 25.5% of the episodes of exacerbations of CB, whereas in the vaccinated group was observed 8.8% of episodes of exacerbations of CB, and no cases of pneumonia (RR = 0.32; 95% CI: 0.13 - 0,78; p < 0.05). Under the annual horizon of the study, the total direct and indirect costs associated with the disease HB in both groups were not significantly different, amounting to rub 2 661.8, and 3395.4 rub per patient with and without vaccination, respectively. In the three-year horizon of the study, reducing outpatient and inpatient episodes of treatment of acute exacerbations of chronic bronchitis will reduce the total economic damage from the disease to 28%. Conclusion. The results obtained demonstrate significant clinical efficacy of vaccination with the use of PCV13 in reducing the number of exacerbations in 2.7 times and high economic efficiency leads to higher costs in the year of vaccination and allow them to forecast substantial savings in subsequent years, reaching 35.1 и 48.3% after 2 and 3 years after vaccination.

Objective. To compare the reactogenicity and immunogenicity of inactivated influenza vaccines: Grippol Plus polymer subunit vaccine, Influvac subunit vaccine, and Vaxigrip split vaccine as part of influenza prevention in people aged 18 - 55 with no pre-existing conditions. Materials and methods. Comparative study of three groups of volunteers with no pre-existing conditions using coded serum samples. Randomisation: 1:1:1. Group 1:100 people vaccinated with Grippol® Plus, Group 2:100 people vaccinated with Influvac, Group 3: 100 people vaccinated with Vaxigrip. The study looked into the levels of specific hemagglutination-inhibition antibodies to influenza viruses in a standard hemagglutination inhibition assay (HAI), with the coding of sera obtained before the vaccination and 28 days post-vaccination. The seroconversion rate (share of patients with the antibody titer increase of more than 4x) and seroprotection rate (share of patients with antibody titer > 1:40) were measured. Reactogenicity was evaluated based on the intensity of systemic and local reactions during the first five days post-vaccination. Results. Reactogenicity: in general the number and intensity of systemic and local reactions in all the groups was insignificant, the reactions were mild and required no treatment with medications. Tolerability levels were high. There was a reliable decline in local reactions to subunit vaccines over time. Immunogenicity: the seroprotection rate for the A/H1N1 strain on day 28 post-vaccination was 95.0% for the Grippol Plus group, 95.0% for the Influvac group, and 96.0% for the Vaxigrip group. The seroprotection rate for the A/H3N2 strain on day 28 post-vaccination was 90.9% for the Grippol Plus group, 90.0% for the Influvac group, and 96.0% for the Vaxigrip group. The seroprotection rate for the B strain on day 28 post-vaccination was 99.0% for the Grippol Plus group, 100.0% for the Influvac group, and 100.0% for the Vaxigrip group. Conclusion: the study found that the Grippol Plus, Influvac, and Vaxigrip vaccines have similar efficacy in vaccination against the A/H1N1, A/H3N2, and В strains 28 days post-vaccination. All the vaccines tested were in line with the CPMP requirements to the immunogenicity of human influenza vaccines. All the vaccines had a similar safety profile, but the incidence of injection site pain, swelling and itching was reliably lower in those vaccinated with the Grippol Plus and Influvac vaccines as compared to the Vaxigrip vaccine.

Goal. Study of the protective activity and safety of acellular pertussis vaccine (APV) using freshly isolated strain of B. pertussis. Materials and methods. Mice-hybrids F1 (CBAxC57Bl6). The B. pertussis strains: vaccine strains No. 305, No. 203, freshly isolated strain No. 287, the test neurotropic strain culture of B. pertussis No. 18323. Protective properties of the APV evaluated in accordance with the guidelines. Toxicity APV was studied by changes of body weight of mice, histamine-sensitizing properties, according to the instructions. The results and discussion. The paper presents the study of the safety and protective activity of three options acellular pertussis vaccine (APV) containing a complex of protective antigens of pertussis microbe: APV1 of vaccine strains of B. pertussis No. 305, serovariant 1.2.0, the gene for the pertussis toxin ptxA2, pertactin prnl gene, genes fimbria 2 and 3 - fim2-1 and fim3A and strain No. 203, serovariant 1.2.3, the gene for the pertussis toxin ptxA4, pertactin prnl gene, genes fimbria - fim2-1 and fim3A; APV2 of freshly isolated strain of B. pertussis No. 287, serovariant 1.0.3, the gene for the pertussis toxin ptxAl, gene pertactin prn2 genes fimbria -fim2-1 and fim3В; APV3 of strains No. 305, No. 203 and No. 287. Shows the relationship between the protective activity of the APV and genetic types, pertussis toxin, pertactin and fimrie in their composition. Protective activity APV1, APV2 and APV3 when infecting dose of 345 LD50 was 9.0 IPU/ml (international protective units per ml) of 10.3 IPU/ml and 19.9 IPU/ml, respectively. At extremely high dose of infection (3846 LD50) protective properties possessed only APV3, protective activity it was 9.2IPU/ml, in line with who requirements - at least 8 IPU/ml. Conclusion. Enhancing the protective effects of the vaccine APV3 and freshly isolated strain can be explained by the stimulation of cellular and humoral immunity to a broader spectrum of antigenic alternative structures in pertussis toxin, pertactin and fimrie.

The aim. The study of phenotypic characteristics and dynamics of sensitivity to antibiotics Russian invasive strains H. influenzae. Materials and methods. Studied 89 Russian invasive strains H. influenzae for the period 13-year period (2004 - 2016). To study metabolic, enzymatic activity and beta-lactamase and biotype characteristics H. influenzae strains. Studied H. influenzae sensitivity to antibiotics. Results. Most strains related H. influenzae serotype b (86,1%), biotype II (69,7%), VII (16,9%), I (13,5%). Ampicillin-resistant strains accounted for 10.1%. All of them produced the enzyme beta-lactamase. Conclusion. The population of the Russian invasive ampicillin-resistant H. influenzae strains accounted for 10.1%. The mechanism of resistance to ampicillin is the production of the enzyme beta-lactamase.

Some data of the complex immune status study of humans vaccinated with live plague vaccine EV are represented. These people constantly reside and work at the territory of Gorno-Altai high-mountain natural plague focus that today demonstrates high epidemic activity. It was shown that 93% of the vaccinated humans developed positive seroconversion in 1 month after immunization, but after 6 months the protective antibody titers significantly decreased and did not exceed the diagnostic level. At the same time the revealed changes of the main immunoglobulin concentrations ranged within the physiological norm. Furthermore, increased production of TNF-and IFN- in blood cells in 1 month after vaccination may indicate the development of cellular immune response in humans immunized against plague and confirms the predominant role of cellular response in comparison with humoral reactions.

We have shown the levels of specific antibodies that can neutralize different strains on the virulence of the virus of tick-borne encephalitis (TBE). Specific immunoglobulin with its titers of 1:100, 1:400 и 1:3200 and two TBEV strains with its doses 3 lg TCID50/ ml (Dal negorsk - highly pathogenic, Primorye-437 - not pathogenic for humans). Evidential basis of the activity of residual virus has been obtained in vitro and in vivo in 3, 24, 48 and 72 hours after infection cells of culture PK and mice neinbrednyh by the test samples. Immunoglobulin does not have a protective effect, if its titer is 1:100; inhibits low virulent strain (P-437), but not Dal negorsk one, if its titer is 1:400; and inhibits both strains, it its titer is 1:3200. Regarding the models of different TBE virus strains, this article suggests new approaches to studying the efficacy of specific vaccine prophylaxis and individual prescription of the amount and terms of revaccination for tick-borne encephalitis.

The results of archive data analysis of the tick-borne encephalitis (TBE) cases in Irkutsk during 1995 - 2015, got from Irkutsk Regional Center for hygiene and epidemiological surveillance, are shown. During the examined period the percent of severe forms and lethal outcomes of the disease have risen. The severe forms came more often at the very beginning and at peak of ticks’ activity season. The number of alimentary TBE cases, illness of anti-TBE vaccinated persons and persons with professional risk of infection have increased in Pribaikalie during 1995 - 2015. The recurring TBE cases have been also recorded.

Division of the Asian part of the Russian Federation into southern and northern zones was implemented on the basis of physical-climatic features. The retrospective analysis of the natural focal infectious diseases in humans was carried out. Spectrum of nosological forms and epidemic process intensity in each of the evolved zones were established. Epidemic manifestations were the most expressed in the Subjects belonging to the southern zone, with domination of the Ixodes tick-borne infections. In northern zone natural focal infections included 57,1 % of local cases, they were registered only in the population of Yamal-Nenets Autonomous Okrug (District), and barely nontransmissible infections: hemorrhagic fever with renal syndrome and rabies.

Epidemiologic patterns of spread of TBE and Lyme Borreliosis in the Kemerovo region within 23 years (1993 - 2015) have been studied. It has been established that sickness rate of TBE has reduced while sickness rate of Lyme Borreliosis has increased. Risk groups and risk areas of distribution of tick-borne infections have been detected. Borrelia DNA has been detected in 35,46 ± 6,26% of ticks, TBE virus antigen has been detected in 2,2 ± 0,28% of ticks. Sickness rate of tick-borne infections and rate of detection of infected ticks differentiate in different areas of the region which therefore should involve differential approach to organization preventive measures.

Kemerovo virus (KEMV), a member of Reoviridae family, Orbivirus genus, is transmitted by ixodes ticks and can cause the damage of human central nervous system. The occurrence and genetic diversity of KEMV in Western Siberia still remained poorly studied, so, the aim of this work was to investigate the prevalence and genetic variability of KEMV in ixodid ticks from Western Siberia. A total of 1958 Ixodes persulcatus, I. pavlovskyi ticks and their hybrids from Novosibirsk and Omsk provinces, Altai Republic (Russia) and East Kazakhstan province (Kazakhstan) were analyzed for the presence of KEMV and tick-borne encephalitis virus (TBEV) RNA. It was shown that KEMV distribution area in Western Siberia was wider and included Northern and Northeastern Altai in addition to Omsk and Novosibirsk provinces. For the first time this virus was found in Kazakhstan. The occurrence of KEMV was statistically lower than TBEV in most locations in Western Siberia. KEMV was found both in I. persulcatus and I. pavlovskyi ticks and in their hybrids. Notably, KEMV variants found in 2010s genetically differ from those isolated in 1960s. Moreover, the possibility of reassortment for KEMV was demonstrated for the first time.

Following article represents an analysis of the epidemiological situation of tick-borne diseases in Moscow. The study presents incidence rates of Lyme borreliosis in Moscow city population and an estimation of Ixodid ticks abundance in «Sokolniki» park and its adjacent part «Losiniy Ostrov». We estimated the prevalence of tick-borne diseases in quested ticks collected from vegetation. We developed recommendations to prevent tick bites of «Sokolniki» park visitors. The article discussed the need to develop specific strategy and tactics for the metropolis to take preventive action against tick-borne diseases.

Recommendations highlighted features vaccination children with hemoblastosis. It is shown how the immunization scheme may be changed according to the pathology and the age of the child.

The complex of actions is presented carried out by the Local Administration of Russian Federal Consumer Rights Protection and Human Welfare Supervision Service in the Rostov Region together with the Ministry of Health of the Rostov Region and Center of Hygiene and Epidemiology in the Rostov Region, aimed at the prevention of influenza and acute respiratory viral infections and including: organizational work, results of epidemiological surveillance during interepidemic and epidemic periods with the epidemiological situation assessment, managerial decision-making on the basis of the results obtained, as well as working with reference-centers. The epidemic rise of incidence in the season of 2015 - 2016 was more intensive judging by the majority of characteristics in comparison with the previous period. The main etiological agent of infection was influenza virus A(H1N1)pdm09 characterized by the early onset of epidemic rise from mid-January 2016, the lesser engagement of children from 3 to 6 years of age into epidemic process but maximal engagement of schoolchildren aged 7 - 14, by the higher rate of disease development, higher per cent of hospitalized with influenza diagnosis, and maximal number of deceased at the peak of epidemic.